Evaluation of Factors Affecting Mortality in Patients with Idiopathic Pulmonary Fibrosis: A 10-Year Single-Center Experience
Tugba Onyilmaz, Serap Argun Baris, Bengugul Ozturk, Gozde Oksuzler Kizilbay, Gozde Selvi Guldiken, Hasim Boyaci, Ilknur Basyigit · 2025
Read Evaluation of Factors Affecting Mortality in Patients with Idiopathic Pulmonary Fibrosis: A 10-Year Single-Center Experience by Tugba Onyilmaz, Serap Argun Baris, Bengugul Ozturk, Gozde Oksuzler Kizilbay, Gozde Selvi Guldiken, Hasim Boyaci, Ilknur Basyigit (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785435.txt.
Description
Tugba Onyilmaz and six co-authors look back over ten years of care for a scarring lung disease in a 2025 study. The disease, idiopathic pulmonary fibrosis, stiffens the lungs and kills many patients, and even with newer drugs, guessing who will fare worst stays hard.
The team reviewed records for 268 patients seen at one large center between 2015 and 2024. Most were men, with a median age of seventy-two. Over a median follow-up of two years, forty-four percent died. Those who died were older and more often had heart artery disease or lung blood clots. The authors sort which traits traveled with death so clinics can plan closer watch and care for the highest-risk patients.
Catalog record
| CREATOR | Tugba Onyilmaz, Serap Argun Baris, Bengugul Ozturk, Gozde Oksuzler Kizilbay, Gozde Selvi Guldiken, Hasim Boyaci, Ilknur Basyigit |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |